Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
15.03
0.36 (2.45%)
At close: Apr 29, 2025, 3:59 PM
15.02
-0.07%
After-hours: Apr 29, 2025, 04:27 PM EDT
Spyre Therapeutics Revenue
Spyre Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending December 31, 2024, Spyre Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
65
Market Cap
905.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 886K | -61.96% |
| Dec 31, 2022 | 2.33M | -87.57% |
| Dec 31, 2021 | 18.74M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |